Robert Taub, a serial entrepreneur and investor in life science – and Olivier Taelman, a seasoned executive in neuromodulation – have invested approximately EUR 1.5 million. Palion Medical (with origins from St. Olavs Hospital and NTNU) have a medical device and a which might help for refractory chronic migraine patients as well as cluster headache patients. “It is very satisfactory to be able to attract best possible investments through such competent investors with highly relevant medical and industrial experience to Palion Medical, and we are very excited about the future for the company.” says chairman Lars Lund-Roland.

Read full press release (PDF)